• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
IMR 2.75% 56.0¢

IMRICOR MEDICAL SYSTEMS INC.

Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging... Imricor Medical Systems, Inc. is a developer of magnetic resonance imaging (MRI)-compatible medical devices, which is used to carry out real-time interventional Cardiac Magnetic Resonance Imaging (iCMR) cardiac ablation procedures. The Company is engaged in designing, manufacturing, and selling MRI-compatible products for cardiac catheter ablation procedures to treat arrhythmias. Its products include Vision-mitral regurgitation (MR) Ablation Catheter, Advantage-MR electrophysiology (EP) Recorder/Stimulator and Vision-MR Dispersive Electrode. The Vision-MR Ablation Catheter is designed to work under real-time MRI guidance. Advantage-MR EP Recorder/Stimulator System provides technology that allows physicians to utilize both the EP recording system and a cardiac stimulator while ablating within the iCMR environment. The Company sells its products to hospitals and clinics for use in iCMR labs, in which ablation procedures using the Vision-MR Ablation Catheter can be performed.More

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
IMR
News: IMR Imricor Medical Systems Says Northstar 3D Mapping System Got IDE Approval From US FDA
26/03/24 0 73
26/03/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  73 
IMR 26/03/24 0 178
26/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  178 
IMR 19/03/24 0 140
TRENDING NEWS

Diversification and low trading fees: Is this the ‘secret sauce’ to saving your investment portfolio?

NEWS
28 Mar 2024
19/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  140 
IMR 19/03/24 0 102
19/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  102 
IMR 19/03/24 0 128
19/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  128 
IMR 11/03/24 1 389
11/03/24 Last post  valueprospector Comments Created with Sketch.  1  Views Created with Sketch.  389 
IMR
News: IMR Imricor Medical Systems Says Visabl-Afl Trial For US FDA Approval Receives Ethics...
11/03/24 0 95
11/03/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  95 
IMR
News: IMR Imricor Medical Systems Says Ethics Committee At Lausanne University Hospital Approved...
08/03/24 0 77
08/03/24 Last post  Hot News Comments Created with Sketch.  0  Views Created with Sketch.  77 

See All Discussions arrow Created with Sketch.

Timeline

IDE Approval of NorthStar 3D from FDA in VISABL-AFL Trial
26 Mar 09:35
 
Ceasing to be a substantial holder
19 Mar 10:50
 
Results of Meeting
19 Mar 10:47
 
Imricor to Present at NWR Virtual Healthcare Conference
19 Mar 09:23
 
Ethics Committee Approval by ICPS for VISABL-AFL Trial
11 Mar 09:46
 
Ethics Committee Approval at CHUV for VISABL-AFL Trial
08 Mar 08:27
 
View More arrow Created with Sketch.
(20min delay)
Last
56.0¢
Change
0.015(2.75%)
Mkt cap ! $105.3M
Open High Low Value Volume
56.0¢ 56.5¢ 54.0¢ $34.99K 62.95K

Buyers (Bids)

No. Vol. Price($)
1 81 56.0¢
 

Sellers (Offers)

Price($) Vol. No.
56.5¢ 21696 1
View Market Depth
Last trade - 13.58pm 28/03/2024 (20 minute delay) ?
Last
56.0¢
  Change
0.015 ( 3.70 %)
Open High Low Volume
54.0¢ 56.0¢ 54.0¢ 15257
Last updated 13.58pm 28/03/2024 ?
IMR (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.